在各种癌症中对酸-3-蛋白激酶 (PI3K) 途径的分子向
Khine S Shan1, Amalia Bonano-Rios1, Nyein Wint Yee Theik2
1Division of Hematology and Oncology, Memorial Health Care, Pembroke Pines, FL 33028, USA.
International journal of molecular sciences
|February 24, 2024
概括
不调节的酸丁-3-酶 (PI3K) 途径驱动癌症. 虽然PI3K抑制剂显示出前景,但它们的临床使用受到疗效,毒性和耐药性的限制,需要进一步研究.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 酸-3-酶 (PI3K) 途径对于细胞功能至关重要.
- 它的失调是细胞失控生长和癌症发展的关键驱动因素.
- 几种PI3K抑制剂已经获得FDA批准,证明了治疗潜力.
研究的目的:
- 审查PI3K信号通路及其在致癌过程中的作用.
- 讨论当前和新兴的PI3K通路抑制剂.
- 探索PI3K抑制剂治疗的挑战,耐药性机制和未来方向.
主要方法:
- 关于PI3K信号的文献综述.
- 在癌症中对PI3K路径改变的分析.
- 关于PI3K抑制剂的临床数据和临床前研究的摘要.
- 检查耐药机制和不良影响.
主要成果:
- PI3K通路失调与许多癌症有关.
- 已批准的PI3K抑制剂已经显示出有效性,但面临局限性.
- 耐药性机制和毒性阻碍了广泛的临床应用.
结论:
- 准PI3K通路仍然是癌症治疗的关键领域.
- 克服耐药性和管理毒性是关键的挑战.
- 新型抑制剂和组合策略对于未来的进展至关重要.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Phosphoinositides and PIPs
8.5K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.5K
Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K


